$ZVSA 4 SEC Filings

Filed On	Filing
16 Jul 2025	Form 4: Cashmere Karen A., Chief Commercial Officer Granted 48,100 Stock Options
15 Jul 2025	Form 4: Freitag Gregory Gene, Director Granted 11,066 Stock Options
15 Jul 2025	Form 4: Glover Stephen C., Director Granted 136,900 Stock Options
15 Jul 2025	Form 4: Finizio Robert G, Director Granted 11,066 Stock Options
15 Jul 2025	Form 4: Wolfe Peter, Chief Financial Officer Granted 60,100 Stock Options
15 Jul 2025	Form 4: Guzman Pablo A., Chief Medical Officer Granted 48,900 Stock Options
15 Jul 2025	Form 4: Park Min-Chul, Director Granted 11,066 Stock Options
15 Jul 2025	Form 4: Sapirstein James, Director Granted 11,066 Stock Options
18 Jul 2024	Form 4: Cashmere Karen A., Director Granted 572 Stock Options
18 Jul 2024	Form 4: Wolfe Peter, Chief Financial Officer Granted 715 Stock Options
18 Jul 2024	Form 4: Glover Stephen C., Director Granted 1,627 Stock Options
18 Jul 2024	Form 4: Park Min-Chul, Director Granted 132 Stock Options
18 Jul 2024	Form 4: Freitag Gregory Gene, Director Granted 132 Stock Options
18 Jul 2024	Form 4: Sapirstein James, Director Granted 132 Stock Options
18 Jul 2024	Form 4: Finizio Robert G, Director Granted 132 Stock Options
03 Aug 2023	Form 4: Incon Co., Ltd., 10% owner
26 Jan 2023	Form 4: Guzman Pablo A., Chief Medical Officer Granted 100,000 Stock Options (right to buy)
20 Dec 2022	Form 4: Wolfe Peter, Chief Financial Officer Received 3,000 shares as a grant or award ($8.64K)
16 Dec 2022	Form 4: Incon Co., Ltd., 10% owner Received 1,497,199 shares as a grant or award · Granted 450,702 Warrant (right to buy)
14 Dec 2022	Form 4: Finizio Robert G, Director Granted 59,562 Stock Options (right to buy)

Comments